NRNadhifa Tazkia Ramadhani

Nadhifa Tazkia Ramadhani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nadhifa Tazkia Ramadhani has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Haemophilia-A in Indonesia: Modified Method for Detecting Intron Inversion and in Silico Approach for Functional Analysis of Three Novel Variants in FVIII Gene

    by Fitri Primacakti, Nadhifa Tazkia Ramadhani, Pustika Amalia Wahidiyat, Novie Amelia Chozie, Damayanti Rusli Sjarif

    Introduction Haemophilia-A is a genetic disorder caused by genetic variations in the factor VIII (FVIII) gene on the q-arm of the X chromosome. Its prevalence reaches 80–85% of all haemophilia cases in the world. The intron-22 inversion is the most common type of genetic variation (50–75%) followed by intron-1 inversion (1–5%). However, the genetic variations of haemophilia-A in Indonesia are not yet extensively studied. This study aims to develop and modify a molecular technique to detect genetic mutation among hemophilia patients in Indonesia, including to find and classify any novel genetic variations within the FVIII gene. Methods Whole blood from severe haemophilia A subjects was used for genomic DNA extraction with a commercial kit. The FVIII gene was amplified by PCR using primers designed via Benchling, NCBI Primer-BLAST, and NetPrimer. PCR products were sequenced by Sanger sequencing and analysed with FinchTV and BioEdit. Novel variants were classified according to ACMG 2015 guidelines with CanVIG-UK updates. Predicted 3D amino acid structures were obtained from AlphaFold and analysed using BIOVIA Discovery Studio 2024. Results This study identified pathogenic genetic alterations in the FVIII gene among patients with haemophilia A. Using inverse-shifting PCR (IS-PCR), we detected intron 22 and intron 1 inversions with distinct amplicon sizes that differentiated patients from controls. The method proved reliable and reproducible across samples and experimental conditions. Sanger sequencing also revealed three novel variants in exon 14: c.2871G > C (p.Leu957Phe), c.3637A > T (p.Ile1213Phe), and c.3640C > T (p.Gln1214Ter). Based on ACMG/AMP guidelines, both missense variants classified as likely pathogenic while one nonsense variant classified as pathogenic. All variants were absent from population databases and associated with clinical findings of low level FVIII activity. Conclusions These findings underscore the utility of combining structural, molecular, and clinical data for accurate diagnosis. Our improved IS-PCR protocol and variant characterization approach offer a practical genetic diagnostic strategy for haemophilia-A in Indonesia.

  • Open Access

    The Genetic Association of Single Nucleotide Polymorphisms of SERPINE1 (rs6092) and IFNAR2 (rs1051393, rs2229207) Genes Is Related to Post Covid-19 Respiratory Syndrome

    by Yulia Ariani, Indra Muhiardi, Indra Gunawan, Nadhifa Tazkia Ramadhani, Shafa Talitha Risti, Riyadi Sutarto, Agus Dwi Susanto

    Background Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, is a global pandemic. Severe cases may develop post-COVID-19 respiratory syndrome, characterized by symptoms persisting ≥4 weeks. In this study, we aim to identify the association of post-COVID-19 respiratory syndromes with variants in the SERPINE1 and IFNAR2 genes which are responsible for regulating fibrinolysis and immune response against viral infection, respectively. Methods We recalled 85 COVID-19 positive subjects who were originally admitted to Persahabatan Central General Hospital, Jakarta, in 2020—2021. We performed TaqMan genotyping on clinically relevant variants at rs1051393 and rs2229207 in IFNAR2 and rs6092 in SERPINE1 and conducted statistical analysis to identify the association of these variants with the clinical manifestations of post-COVID-19 respiratory syndrome. Results We found that patients with post-COVID-19 respiratory syndrome had greater disease severity at admission (p = 0.02) and during hospitalization (p = 0.004), along with longer hospital stays (p = 0.0001), possibly due to poorer radiological findings at admission (p = 0.013) and discharge (p = 0.001). Variants in SERPINE1 and IFNAR2 showed significant associations: rs1051393 ( IFNAR2 ) with fever (p = 0.037), and rs2229207 with chest pain (p = 0.047), higher potassium (p = 0.001), chloride (p = 0.047), and pCO 2 (p = 0.030). Additionally, rs6092 ( SERPINE1 ) was linked to increased basophils (p = 0.027) and eGFR (p = 0.036). After Benjamini–Hochberg correction, only disease severity during hospitalization (padj = 0.021), radiological findings at admission (padj = 0.052) and discharge (padj = 0.008), hospitalization duration (padj = 0.00016), and the association of rs2229207 with potassium levels (padj = 0.003) remained significant. Conclusion Our findings suggested the potential contribution of genetic predispositions in the SERPINE1 and IFNAR2 genes to the emergence of post-COVID-19 respiratory symptoms, providing additional consideration in treatment management to improve the outcomes of patients positive for COVID-19.

  • Open Access

    Mutational and Functional Impact of β-globin Gene Mutation in Indonesian Thalassemia Patients using in Silico Method

    by Sri Mufti Ardani, Nadhifa Tazkia Ramadhani, Yulia Ariani, Budi Wiweko, Pustika Amalia Wahidiyat

    Introduction Indonesia is located along the “Thalassemia Belt,” a hotspot region for hemoglobinopathies, including beta thalassemia, with approximately 3–10% of the Indonesian population diagnosed with this disease. Thalassemia was diagnosed using the Hb analysis results. However, the single nucleotide variant (SNVs) database for the Indonesian population, which leads to β-thalassemia disease, has not been extensively studied. This study aimed to profile the genetic variations in Indonesian β-thalassemia patients and conduct in silico characterization of their functional effects. Methods Twenty thalassemia patients were recruited for this study. The sample collected from the respondents was whole blood in EDTA tubes, with a minimum collection time of 14 days after blood transfusion. Genomic DNA (gDNA) was extracted using a commercial kit, directly amplified using Polymerase Chain Reaction (PCR) with specific primers for β-globin and sequenced using Sanger Sequencing. All variants located in exon regions were analyzed using FinchTV, BioEdit, and Biovia Discovery Studio to determine their functional impact. Results Ten reported pathogenic variants were observed along with one rare variant. Genetic variations found according to its common name and nomenclature based on Human Genome Variation Society (HGVS) are IVS1nt.1 (HGVS: c.92+1G>A), IVS1nt.1 (HGVS: c.92+1G>T), IVS1nt.2 (HGVS: c.92+2G>T), IVS1nt.5 (HGVS: c.92+5G>C), IVS2nt.654 (HGVS: c.316-197C>T), Cd15 (HGVS: c.47G>A), Cd26 (HGVS: c.79G>A), Cd30 (HGVS: c.92G>C), Cd41/42 (c.126_129delCTTT), and Cd35 (HGVS: c.110delC). Analysis of amino acid interactions revealed that disease-causing mutations were clinically relevant in each subject. Conclusions This study has bioinformatically proven the effect of genetic mutations and predicted their effect on amino acid interactions. These findings contribute to the study of Indonesian thalassemia and require further research.


  • Open Access

    Association between Musculoskeletal Status and Genetic Mutations in Patients with Hemophilia A

    by Fitri Primacakti, Pustika Amalia Wahidiyat, Damayanti R. Sjarif, Novie Amelia Chozie, Naura Anindya Candini, Joedo Prihartono, Ninik Sukartini, Nadhifa Tazkia Ramadhani, Bidasari Lubis

    Introduction: Hemophilia A is an inherited bleeding disorder caused by mutations in the factor VIII (FVIII) gene. These mutations result in either reduced FVIII synthesis (null variants) or loss of FVIII function (non-null variants). Null variants are typically associated with more severe FVIII deficiency and recurrent joint bleeding, which may adversely affect musculoskeletal health. Objective: To evaluate the relationship between musculoskeletal status and genetic mutations in patients with hemophilia A. Methods: A cross-sectional study was conducted at the Faculty of Medicine Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital from June 2024 to March 2025. Genetic analysis was performed at the Human Genetic Research Center using inverse-shifting PCR and Sanger sequencing. Mutations were classified as null variants (intron-22 inversion, intron-1 inversion, large deletion, and nonsense mutations) and non-null variants (missense and non-conserved splice mutation). Musculoskeletal status was assessed by the presence of target joints and the Hemophilia Joint Health Score (HJHS), which evaluates global gait and joint function of the elbows, knees, and ankles. Higher HJHS scores indicate worse joint health. Results: Sixty patients were included in this study, of which 39 had severe, 15 had moderate, and the remaining 6 had mild hemophilia A. The median age was 9.5 years (range 2-18). Null variants were identified in 45/60 patients and non-null variants in 15/60 patients. The most common target joints were the knees in patients with null variants and the ankles in those with non-null variants. The median HJHS was 4 (Q1-Q3: 2-13.5) in the null variant group and 2 (Q1-Q3: 1-11) in the non-null variant group. No significant association was observed between the target joint and the HJHS and genetic mutations. Further subgroup analysis showed no difference in HJHS between mutation groups among patients receiving prophylaxis (p=0.366) or on-demand treatment (p=0.458). Conclusion: No association was found between genetic mutation type and musculoskeletal status in patients with Hemophilia A. HJHS did not differ between mutation groups regardless of treatment regimens.

  • Open Access

    The Genetic Association of Single Nucleotide Polymorphisms of SERPINE1 (rs6092) and IFNAR2 (rs1051393, rs2229207) Genes Is Related to Post Covid-19 Respiratory Syndrome

    by Yulia Ariani, Indra Muhiardi, Indra Gunawan, Nadhifa Tazkia Ramadhani, Shafa Talitha Risti, Riyadi Sutarto, Agus Dwi Susanto

    Background Coronavirus disease 2019 (Covid-19) is a disease of the respiratory system caused by the SARS-CoV-2 virus. The severity of Covid-19 can be affected by the presence of single nucleotide polymorphisms (SNPs) in certain genes, such as IFNAR2 and SERPINE-1. This study aimed to identify and analyze the presence of SNP rs6092 in the SERPINE1 gene and rs1051393 and rs2229207 in the IFNAR2 gene relation in Covid-19 respiratory syndrome in Indonesia. Methods DNA was isolated from saliva samples of all patients, and a TaqMan Genotyping Assay with a real-time PCR instrument was used to run the samples. The output data were analyzed for demographic data, allele frequency, genotype frequency, and the association of all SNPs with the Covid-19 respiratory syndrome (case) and control subjects. We also analyzed blood laboratory results, blood gas analyses, coagulation factors, and inflammatory factors using SPSS. Results This study included 85 subjects comprise with Covid-19 respiratory syndrome and control subjects. Our study found no association between subjects with Covid-19 respiratory syndrome and any of the variants. However, based on the symptoms caused by rs1051393, we found that it had an effect on fever symptoms. In addition, a significant relationship between rs2229207 and chest pain symptoms was observed in patients with case group. Furthermore, our study found significant differences (p < 0.05) in several blood laboratory analyses, such as the level of basophils and eGFR for rs6092 and the potassium level for rs2229207. Furthermore, arterial blood gas analysis showed that pCO2 and pH levels were significantly different for rs2229207. Conclusion Our study found an association between rs1051393 and fever and between rs2229207 and chest pain in patients with post Covid-19 respiratory syndrome.

  • Open Access

    DNA quality from buccal swabs in neonates: comparison of different storage time

    by Klara Yuliarti, Muchtaruddin Mansyur, Ina Susianti Timan, Yulia Ariani, Ernawati, I Gusti Lanang Sidhiarta, Nadhifa Tazkia Ramadhani, Nurul Muhammad Prakoso, Damayanti Rusli Sjarif

    BACKGROUND Genomic medicine has great potential for diagnoses, disease prediction, and targeted treatment. Buccal swabs are a suitable non-invasive method for neonates to obtain DNA samples. Due to Indonesia's geographical conditions, samples require a prolonged time to reach the genetic laboratory. This study aimed to compare the DNA quality of buccal swabs in neonates between immediate and after-storage extraction. METHODS This study was part of a study about the profile of human milk oligosaccharide and FUT2 genotype in Indonesian mother-infant dyads consisting of 20 neonates. 1 swab stick for each participant was taken using a standardized buccal swabbing protocol and divided into 2 isovolume aliquots, which were grouped into the immediate (extraction was performed within 3 days after sampling) and storage groups (extraction was performed on the 14th day after storage in 4°C). DNA yield and purity A260/280 ratio were measured by spectrophotometry. The PCR amplification and Sanger sequencing were performed to validate the DNA isolate quality for downstream application. RESULTS The DNA yield for the immediate group was similar compared with the storage group (9.50 [4.89] versus 9.10 [5.05] µg), p = 0.659, as well as DNA purity A260/280 (1.58 [0.24] versus 1.56 [0.28]), p = 0.785. PCR and sequencing of FUT2 results also showed similar quality between both groups. CONCLUSIONS The similar DNA quality and sequencing results between immediate and storage extraction confirmed that buccal swabs could be stored for 2 weeks, allowing ample time for sample shipping from remote areas to the laboratory.